Commentary regarding Schayek et al., entitled "The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil".
Post-Graduate Programs in Epidemiology and in Genetics and Molecular Biology, Federal University of Rio Grande do Sul (UFRGS), Brazil; Genomic Medicine Laboratory, Hospital de Clinicas de Porto Alegre (HCPA), Brazil.
Fernanda
F
Sales Luiz Vianna
Post-Graduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul (UFRGS), Brazil; Genomic Medicine Laboratory, Hospital de Clinicas de Porto Alegre (HCPA), Brazil.
Barbara
B
Alemar
Department of Oncogenetics A.C. Camargo Cancer Center, São Paulo, Brazil.
Maria Isabel
MI
Achatz
Post-Graduate Program in Epidemiology and Department of Statistics, Federal University of Rio Grande do Sul (UFRGS), Brazil.
Suzi Alves
SA
Camey
Post-Graduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul (UFRGS), Brazil; Genomic Medicine Laboratory, Hospital of Porto Alegre (HCPA), Brazil. Electronic address: pprolla@gmail.com.
Patricia
P
Ashton-Prolla
D024682:BRCA2 Protein / Q000235:genetics*; D001938:Brazil; D001943:Breast Neoplasms / Q000453:epidemiology; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D009154:Mutation; D010051:Ovarian Neoplasms / Q000453:epidemiology*
D024682:BRCA2 Protein